Inadequate Efficacy and Safety Reporting for FDA-Cleared AI/ML-Enabled Medical Devices
OVERVIEWA comprehensive review by Vera Health finds that FDA-cleared AI and machine learning-enabled medical devices often lack adequate reporting of efficacy and safety data, creating a regulatory blind spot for post-market surveillance and clinical validation. The finding reveals a critical gap between FDA clearance and clinical evidence: devices can receive regulatory authorization without robust demonstration of clinical benefit or comprehensive safety monitoring. This gap is particularly concerning for AI systems that may behave differently across patient populations or clinical contexts. The inadequate reporting framework means that clinicians and health systems deploying FDA-cleared AI devices have limited visibility into real-world performance, adverse events, or long-term outcomes. Reform of FDA reporting requirements for AI devices is now emerging as a regulatory priority. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.